| Applications: | Immunodepletion/Immunocompetition |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description : | Baboon Blocking Peptide for STJ500204 is synthetically produced from the 552-572 sequence and is suitable for use in western blot applications. |
| Formulation: | Liquid form at 2.5mg/ml concentration in PBS. Up to 5% DMSO can be added. Orders with >1mg can be supplied in lyophilized powder form, or in buffer of choice. |
| Dilution Range: | WB: IHC: 1:200ICC: 1:200IF: 1:200CFM: 1:200 |
| Storage Instruction: | Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
| Immunogen Region: | 552-572 |
| Specificity: | This blocking peptide is recommended for use in combination with Baboon antibody, STJ500204 |
| Immunogen: | C-epitope Synthetic peptide corresponding to amino acids 552-572 of Drosophila melanogaster Baboon protein. Peptide was covalently modified. Sequence: QPDPSIEEMKKVVCIEKCRPN |
| Background | Invovled in activin binding, GPCR kinase activity, serine threonine kinase activity and transforming growth factor beta receptor activity. |
Information sourced from Uniprot.org